At a glance
- Calvert's portfolio looks much as it did five years ago, with Thermo Fisher Scientific (TMO) and Danaher (DHR) still fending off new challengers.
- The fund has drifted from large growth toward large blend.
- Advisors who screen on Morningstar Process ratings will now see both funds at Average rather than Above Average, so a model or watchlist filtered for Above Average Process will exclude them.
Morningstar downgraded the Process ratings on Calvert Equity (CSIEX) and Baron Generational Growth (BGRFX) to Average from Above Average. It said neither fund's philosophy is broken; each no longer shows enough of an advantage in generating and acting on ideas to keep the higher rating.
Calvert's portfolio looks much as it did five years ago, with Thermo Fisher Scientific (TMO) and Danaher (DHR) still fending off new challengers. The fund has drifted from large growth toward large blend. Baron responded to persistent outflows by selling smaller positions, leaving 18 stocks in September 2026 versus about 60 a decade earlier, with nearly 90% of assets in its top 10.
Advisors who screen on Morningstar Process ratings will now see both funds at Average rather than Above Average, so a model or watchlist filtered for Above Average Process will exclude them.
Reported by the Products & portfolios desk from Morningstar — Financial Advice. Published . Corrections